glp-1 kidney protection Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis Cardiorenal Protection in Diabetic Kidney

GIP receptor activation enhances insulin secretion and is hypothesized to affect fat metabolism, while GLP-1 receptor agonism promotes satiety, slows gastric emptying, and reduces appetite

Effects of Once-Weekly Semaglutide on Appetite, Energy Intake, Control of Eating, Food Preference and Body Weight in Subjects with Obesity

Lowering the cost of Ozempic may increase the population at risk for these serious health conditions, ultimately endangering more people with its dangerous side effects

adults was conducted in November 2025 to understand perceptions and experiences surrounding GLP-1 access and affordability

For some people, it hits hard right after

Rare but serious risks include pancreatitis, gallbladder disease, and thyroid tumors (seen in rodent studies